Intervention: Pregabalin

POSTCOVID

Poland
|
2023-2028
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Pregabalin